2Muller-Breitkreutz K.Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997.EPFA Working Group on Quality Assurance[J].Vox Sang,2000,78(3):149-157.
3Seed CR,Cheng A,Ismay AL,et al.Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV RNA donor screening in Australia and the implications for future HBV NAT[J].Transfusion,2002,42(10):1365-1372.
4Shang GF,Seed CR,Wang F,et al.Residual risk of transfu-sion-transmitted viral infections in Shenzhen,China,2001 through 2004[J].Transfusion,2007,47 (3):529-539.
5Soldan K,Davison K,Dow B.Estimates of the frequency of HBV,HCV and HIV infectious donations entering the blood supply in the United Kingdom,1996 to 2003[J].Euro Surveill,2005,10(2):17-19.
